You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.īy using this site, you agree to the Terms of Service and Privacy Policy. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. All timestamps are reflected in IST (Indian Standard Time).ĭISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. (for corporate data, historical price & volume, F&O data). As on 30-09-2021, the company has a total of 24.84 Crore shares outstanding.ĭATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. and Krabbe also connect dialogues to sequents by introducing their dialogical. The company’s top management includes Dr.Kamal K Sharma, Mr.Manish Gupta, Mr.Sharat Narasapur, Mr.Gregory John Andrews, Mr.Neeraj Bharadwaj, Dr.Fabian Kausche, Mr.Rahul Mukim, Mr.Milind Sarwate, Dr.(Mrs.)Kausalya Santhanam. Considering a sequent, corresponds to concessions by O and to. Company has reported net profit after tax of Rs 2.65 Crore in latest quarter. For the quarter ended 30-06-2021, the company has reported a Consolidated Total Income of Rs 323.18 Crore, down 11.02 % from last quarter Total Income of Rs 363.20 Crore and up 3.65 % from last year same quarter Total Income of Rs 311.81 Crore. key Products/Revenue Segments include Bulk Drugs, Chemicals, Duty Drawback, Other Operating Revenue and Scrap for the year ending 3. Sequent Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 5,275.40 Crore) operating in Pharmaceuticals sector.

Sequent connect